InvestorsHub Logo
Followers 7
Posts 650
Boards Moderated 1
Alias Born 06/02/2009

Re: None

Wednesday, 10/20/2010 9:59:48 AM

Wednesday, October 20, 2010 9:59:48 AM

Post# of 240
Santarus also plans to initiate a Phase I clinical study in the first half of 2011 with its anti-VLA-1 antibody that the company expects to investigate for the treatment of rheumatoid arthritis.

This is forward looking, but currently, there are no good know cures for rheumatoid arthritis that I'm aware of.

ASCO Annual Meeting, June 4-9, 2010, Chicago IL